CRISPR gene editing heads to human trial as cancer treatment

[Celebrity]

U.S. advisory panel gives OK to human trials for gene-editing to target melanoma, myeloma, sarcoma

Approval in the U.S. of a human trial using the gene-editing technique called CRISPR to target certain cancers could open the door to dozens of trials using the promising new technology.

A National Institutes of Health advisory panel earlier this week approved a University of Pennsylvania trial of CRISPR in treatment of myeloma, melanoma and sarcoma.

The experiment still must be approved by the Food and Drug Administration, which regulates clinical trials, as well as regulators at the institutions where the work is being done.

Could this research be a parallel interest to stem cell research?

CRISPR gene editing heads to human trial as cancer treatment - Health - CBC News

 

[nota bene]

Here is an article that touches on some of the ethical concerns: First Studies In CRISPR Gene Edit Technique Approved in UK